BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9279344)

  • 1. [TUT-7 early phase II clinical study for various solid tumors and hematologic malignancies].
    Taguchi T; Wakui A; Niitani H; Furue H; Majima H; Ota K; Ariyoshi H; Hattori T; Sugimachi K; Tsukagoshi S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1253-61. PubMed ID: 9279344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bropirimine (U-54461S) early phase II clinical studies--to investigate the efficacy and safety of bropirimine treatment on various malignant tumors (urological, hematologic, and dermal cancers)].
    Furue H; Machida T; Masaoka T; Ikeda S
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):67-75. PubMed ID: 9020948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Menogaril (TUT-7) late phase II study for malignant lymphoma, adult T-cell leukemia and lymphoma (ATLL)].
    Taguchi T; Ohta K; Hotta T; Shirakawa S; Masaoka T; Kimura I
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1263-71. PubMed ID: 9279345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early phase II clinical trial of amrubicin hydrochloride in patients with malignant lymphoma].
    Masaoka T; Ogawa M; Inoue K; Sanpi K; Kuraishi Y; Toki H; Tamura K; Takagi T; Shibata A; Hirano M; Ezaki K; Shirakawa S; Matsuda T; Kimura I
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1857-65. PubMed ID: 11729478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late phase II clinical study of amrubicin hydrochloride, a novel synthetic anthracycline derivative anticancer agent, for malignant lymphoma].
    Akutsu M; Kano Y; Ogawa M; Miura A; Hirano M; Masaoka T; Tatsumi N
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1867-76. PubMed ID: 11729479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [TUT-7 phase I clinical study. TUT-7 Study Group].
    Taguchi T; Wakui A; Niitani H; Furue H; Majima H; Nakao I; Ota K; Hattori T; Sugimachi K
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1125-33. PubMed ID: 9239166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group].
    Noda K; Tanaka K; Ozaki M; Hirabayasi K; Hasegawa K; Nishiya I; Yakushiji M; Izumi R; Tomoda Y; Ogita Y; Sugimori H; Yamabe T; Kudo R; Yajima A; Terashima Y; Fujii S; Suzuoki Y; Okada H; Kono I; Ochiai K; Yamamoto T; Ikeda M; Umesaki N; Saito T; Niitani H
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2061-8. PubMed ID: 9838908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II study of KRN8602 (MX2) for malignant lymphoma].
    Okabe K; Sampi K; Kuraishi Y; Takemoto Y; Tamura K; Ogawa M
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1001-6. PubMed ID: 9644314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for cervical cancer of the uterus].
    Noda K; Ikeda M; Yakushiji M; Nishimura H; Terashima Y; Sasaki H; Hata T; Kuramoto H; Tanaka K; Takahashi T
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):885-92. PubMed ID: 1605666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early phase II study of KRN8602 (MX2), a novel anthracycline derivative for acute leukemia].
    Takemoto Y; Sampi K; Kuraishi Y; Toki H; Tamura K; Ogawa M
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2243-8. PubMed ID: 9881081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bropirimine (U-54461S) late phase II clinical study for carcinoma in situ of the bladder. Japan Bropirimine Study Group].
    Akaza H; Shimazaki J; Tashiro K; Kotake T; Okajima E; Kagawa S; Machida T
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):77-85. PubMed ID: 9020949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].
    Saeki T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Taguchi T
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):539-47. PubMed ID: 15114697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of clinical study with epirubicin hydrochloride injectable solution and cyclophosphamide in breast cancer].
    Koyama H; Adachi I; Tajima T; Kanda K; Yoshida M; Miura S; Nakao K; Kikkawa N; Takai S; Toge T; Tamura K; Inaji H; Shiba E
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1721-9. PubMed ID: 9757198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. THP Study Group].
    Kimura K
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):368-75. PubMed ID: 3947112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Late phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical cancer. ETP 21 Study Group--Cervical Cancer Group].
    Ikeda M; Noda K; Hiura M; Tamaya T; Ozaki M; Hatae M; Ozawa M; Yamabe T; Tanaka K; Izumi R; Okada H; Ogita Y; Hoshiai H
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2249-57. PubMed ID: 9881082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
    Noda K; Hirabayashi K; Terashima Y; Ozaki M; Yakushiji M; Hatae M; Kanazawa K
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1285-93. PubMed ID: 9279348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer--clinical investigation of adverse events].
    Kamiura S; Kobayashi K; Ohira H; Seino H; Hashimoto N; Sawai K; Samejima Y; Saji F
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):979-86. PubMed ID: 11478148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase II study of (2''R)-4'-O-tetrahydropyranyldoxorubicin (THP) in patients with advanced gastrointestinal cancer--a report of the Tohoku THP Study Group].
    Wakui A; Yokoyama M; Yoshida Y; Kikuchi Y; Osawa I; Masamune O; Matsuoka T; Sato S; Kikuchi K; Shoji T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1032-7. PubMed ID: 3963848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A phase I trial of idarubicin by oral administration].
    Ogawa M; Kimura K; Taguchi T; Wakui A; Hattori M; Shimoyama T; Fujita H
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1896-900. PubMed ID: 3473981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.